All
Are you being over-radiated?
New FDA sunscreen rules
Living my dream ... with cancer
Figuring Out Fatigue
Learn tips on figuring out what causes cancer-related fatigue and how to manage it.
New Treatment Offers Relief from Bone Marrow Disorder
Patients with myelofibrosis have few options for relief from an enlarged spleen, a side effect of the cancer, but there is hope on the horizon.
Lymph Node Radiation Better for Some Breast Cancer Patients
Regional lymph node radiation could benefit certain patients.
Laura Ziskin's legacy of Stand Up to Cancer lives on
For Acute Lymphoblastic Leukemia Patients, New Hope from an Old Treatment
New research has shown that high-dose methotrexate improved five-year event-free survival for ALL patients with no significant differences in toxicities.
Dating After Cancer
When it comes to revealing your cancer treatment results, timing is everything.
Proteasome inhibitors in myeloma: The next generation
Pair of Melanoma Studies Usher in a New Standard of Therapy for Patients with Advanced Disease
Melanoma studies with Yervoy and vemurafenib show benefit in advanced disease.
Aromasin Reduces Breast Cancer Risk in Healthy Older Women
Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention.
Iniparib Disappoints in Breast Cancer, But Study Results Hint at Second-Line Therapy Benefit
Latest study results on PARP inhibitor iniparib disappointing, but may be helpful in second-line therapy.
Biomarker Reveals Who Is at Highest Risk for Neuropathy
Biomarker research might reveal neuropathy risk with certain cancer therapies.
Men May Be at Greater Risk Than Women for Developing HPV-Related Cancers
HPV-positive oral cancers are on the rise.
Avastin Continues to Show Impressive Results in Ovarian Cancer
Avastin appears to reduce relative risk of disease progression in recurring ovarian cancer.
Measuring Circulating Tumor Cells Could Predict Prostate Cancer Treatment’s Success
New cancer cell-trapping method could result in improved treatment.
The evolving PARP inhibitor story
Celebrating Life
Dr. Younes highlights important lymphoma studies from ASCO
For acute lymphoblastic leukemia patients, new hope from an old treatment
New treatment offers relief from bone marrow disorder
Early-phase melanoma study adds to "Melanoma" ASCO
A one-in-a-billion chance at success
Men may be at greater risk than women of developing HPV-related cancer
No longer at war?
Phase 1 trial shows promise in personalized therapy approach
Forty years later
CURE's "beat cancer" playlist
A preview of ASCO – The new way of doing clinical trials
